Navigation Links
Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
Date:11/9/2007

ed thus far in the discovery of drugs that will inhibit this pathway without causing excessive toxicity.

To date, over 1,500 patients have been treated with perifosine in trials conducted both in the US and Europe. Its safety profile is distinctly different from that of most cytotoxic agents. It does not cause myelosuppression (depression of the immune system) or alopecia (hair loss) like many currently available treatments for cancer. In phase 1/2 trials it has induced tumor regressions and/or caused disease stabilization in a variety of tumor types. Responding patients, including stable disease, have been treated for months to almost 3 years, on both the daily and weekly schedule.

KRX-0401 (perifosine) is in-licensed by Keryx from Aeterna Zentaris, Inc. (Nasdaq: AEZS; TSX: AEZ) in the United States, Canada and Mexico.

About Renal Cell Carcinoma

In 2007, an estimated 51,000 new cases of RCC and 13,000 deaths attributable to RCC are expected in the US. The National Cancer Institute reports a rising incidence of RCC at a rate of approximately 2% per decade. The disease occurs predominantly in the seventh and eighth decades in life, and it affects nearly twice as many men as women.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide oral gelcap), previously referred to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabete
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ -- BioTrends Research Group, Inc. release...report, the first in a multi-phase syndicated mark...r Ortho-Biotech,s Stelara, from product launch thr...ave of the report provides quantitative informatio...formation from a subset of 20. The reports assess...
(Date:11/25/2009)...ov. 25 AMPAC Fine Chemicals LLC (A...(Nasdaq: APFC ) announced today that it received ...y Award at the Annual Statewide Environmental Summ...Technology Association (CMTA), the Industrial Envi...try Council of California (CICC) held in San Diego...
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Mammography Equipment - A Global Ma...com/p0164330/Mammography-Equipment---A-Global-Mark...ast cancer in industrialized as well as developing...in the mammography market. Globally, escalating aw...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Orthopaedic Surgeon and AOSSM President Dr James Andrews to Discuss Injury Prevention 61098 1Orthopaedic Surgeon and AOSSM President Dr James Andrews to Discuss Injury Prevention 61098 2Orthopaedic Surgeon and AOSSM President Dr James Andrews to Discuss Injury Prevention 61098 3Sigma Aldrich 28Nasdaq 3A SIAL 29 Declares Quarterly Dividend 14787 1Cholesterol Measurements May Be Made Easier 61096 1Cholesterol Measurements May Be Made Easier 61096 2
...ov. 20 The following statement,was released today...an of,the Committee for Pro-Life Activities at the...Studies published this week in the journals Cell a...research and therapies while fully respecting,the ...Wisconsin used four genes to ,reprogram,ordinary a...
...kespeople to Drive Young People to Do Something Ra... WASHINGTON, Nov. 20 Look out for the Kick Me,sig...nd the nation.,YouthAIDS, an action-based initiati...l (PSI), today announced the launch of the 2007 ,K...hildish prank and turns it into,a powerful tool to...
Other Medicine Technology:Stem Cell Breakthrough Advances Science Without 'Ethical Landmines,' Says Cardinal 2YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country 2YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country 3
(Date:11/27/2009)...LY-SUR-SEINE, France, Nov. 27 Team...l cycling team dedicated to ethical sporting and d..., announced today that it will become Team Garmin-...al as a new sponsor of the team. Transitions Optic... eyewear, offering the most advanced photochromic ...
(Date:11/27/2009)...ing unprecedented medical, economic burdens, study... News) -- The number of people with diabetes in th...t 25 years, a new study predicts. , That would ...le with the disease, up from 23.7 million today. ,... with diabetes will triple, the study also warns, ...
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...ars, the number of Americans living with diabetes ...n 2009 to 44.1 million in 2034. Over the same peri...g from $113 billion to $336 billion, even with no ... based at the University of Chicago report in the ...of those with diabetes covered by Medicare will ri...
(Date:11/26/2009)... No more letters from the North Pole, Textsa... messages from Santa , No...perational efficiencies at the North Pole Santa Cl...dren all over the globe informed of his Christmas ...uo;s research department have identified a large a...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
... March 27, 2008 The Cystic Fibrosis Foundation an...ment that targets a basic defect in CF, showed pro...al for patients who carry the G551D mutation of CF...eral key indicators of cystic fibrosis, including ...
...ss., March 27, 2008 -- Harvard University research...t plays an exclusive and unusual role in mice: det...tion in the physical arrangement of their dendrite...scientists Joshua R. Sanes and Markus Meister, is ...
...en, March 27 Cellectricon, a leading,provider of ...unced the,launch of the new Cellaxess(R)HT System.... transfection system enables reagent-free delivery...in,St. Louis, MO, USA, April 6-10., Cellectricon ...
...top choice for Email Encryption in healthcare indu...R)), (Nasdaq: ZIXI ), the leader in email encrypt...at Beatrice Community Hospital,and Health Center i... us,confidence with our email encryption decision,...
...Earned ,Benefits, Respect, Thanks, - Peake, Fourt...June 20, WASHINGTON, March 27 Recognizing the va... women veterans, the,Department of Veterans Affair...rea, Vietnam, the Gulf War, the current Global War...
...d AIDS Leadership Award Recognizes Visionary Advoc...ndation,announced today that AIDS advocate Gregg G...ient of the $100,000 John M. Lloyd AIDS Leadership...lifesaving drugs. He is currently based in Cape To...
Other Medicine News:Health News:Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770 2Health News:Scientists learn what's 'up' with a class of retinal cells in mice 2Health News:Cellectricon Launches World's First System for High Throughput RNAi Screening 2Health News:Beatrice Community Hospital and Health Center Selects Zix Corporation for Email Encryption Service 2Health News:VA Reaches Out to Women Veterans 2Health News:VA Reaches Out to Women Veterans 3Health News:AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award 2Health News:AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award 3
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: